Results 231 to 240 of about 24,826 (263)

Lipoprotein Lp(a): Structure and Metabolism

1989
The Lp(a) antigen was first detected in human plasma by Berg [1]. Although initially thought to represent a genetic variant of LDL, it was later shown to be associated with a specific lipoprotein fraction that is now commonly termed Lp(a) (for recent review see [2]).
V. W. Armstrong, H. Kratzin, D. Seidel
openaire   +1 more source

Lp(a) Lipoproteins and the Genetic Polymorphisms of Lipoprotein B

1976
In this chapter, lipoproteins are denominated according to the three main nomenclature systems currently in use. In addition, trivial names were adopted primarily to designate allotypic lipoproteins. Attempts have been made by the author either to accept terms used in the original publications or to denote lipoproteins according to their apparent ...
openaire   +1 more source

Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association

Arteriosclerosis, Thrombosis, and Vascular Biology, 2022
Gissette Reyes-Soffer, Henry N Ginsberg, Lars Berglund   +2 more
exaly  

Lp(a) lipoprotein level and longevity.

Annales de genetique, 1992
Lp(a) lipoprotein forms a distinct class of serum lipoproteins. Its unique immunochemical properties are caused by the Lp(a) polypeptide chain which is attached to apolipoprotein B (apoB) by a disulfide bridge. The level of Lp(a) lipoprotein is under strict genetic control. It is well established that a high level of Lp(a) lipoprotein is a genetic risk
K, Berg, O C, Rø
openaire   +1 more source

Lp(a) (Lipoprotein[a]) Concentrations and Incident Atherosclerotic Cardiovascular Disease

Arteriosclerosis, Thrombosis, and Vascular Biology, 2021
Aniruddh P Patel, Minxian Wang, James P Pirruccello   +2 more
exaly  

Serum lipoprotein Lp(a) in obesity.

Diabetes research (Edinburgh, Scotland), 1994
Lipoprotein(a) [Lp(a)] has been added to the list of independent risk factors for cardiovascular disease (CVD), whose incidence is greater in obese subjects. There are few data available on the serum Lp(a) concentrations in obese individuals with or without insulin dependent diabetes mellitus (NIDDM).
M, Donatelli, S, Verga, M, Vaccaro, V, Russo, M L, Bucalo, A, Scarpinato   +5 more
openaire   +1 more source

Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States

Journal of the American Heart Association, 2023
Harpreet S Bhatia, Samantha Hurst, Wenhong Zhu   +2 more
exaly  

Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study

Journal of the American Heart Association, 2021
Hiroaki Ikezaki, Elise Lim, L Adrienne Cupples   +2 more
exaly  

Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge

Clinical Chemistry, 1972
Robert I Levy, Donald S Fredrickson, Fredrickson Donald S   +2 more
exaly  

GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism

Cell Metabolism, 2019
Stephen G Young, Loren G Fong, Anne P Beigneux   +2 more
exaly